Mangalam Drugs & Organics Limited (MANGALAM.NS) NSE

Currency In INR

AD

Valuation

Market Cap429.76M
Enterprise Value1.48B
P/E Ratio-1.21
PEG Ratio0.02
Price/Sales Ratio0.18
Price/Book Ratio0.53
Enterprise/Revenue0.52
Enterprise/EBITDA-19.11

Fiscal Year

Fiscal YearMarch 31, 2026
Most Recent QuarterSeptember 30, 2026

Profitability

Profit Margin-0.15
Operating Margin-0.09
AD

Management Effectiveness

Return On Assets-0.13
Return On Equity-0.36

Income Statement

Revenue2.32B
Revenue/Share165.71
Gross Profit232.46M
EBITDA-149.03M
Net Income-444M
Diluted EPS-28.05

Balance Sheet

Total Cash8.35M
Total Cash/Share0.53
Total Debt903.89M
Total Debt/Equity1.03
Current Ratio0.74
Book Value Per Share55.55

Price History

52-Week Change-53.37
52-Week High63
52-Week Low22.8
Moving Average 50 Days30.97
Moving Average 200 Days29.99

Statistics

Average Volume54,247
Shares Outstanding15.83M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A
AD